Staining Methods of Immunohistological Examination
Paraffin blocks obtained from seven sites (the medulla oblongata, C-2, C-5, T-2, T-5, T-8, and the conus medullaris, defined here as the lumbosacral segment receiving dorsal roots L2-S3) were cut serially with a microtome to a thickness of 10 m. The sections were placed on slides coated with 1% poly-L-lysine and dried in an oven at 55˚C for 48 hours. Thereafter, the sections were treated with xylene to remove the paraffin, then rehydrated and incubated in the following solutions: 0.25% Triton X-100 for 30 minutes at room temperature; Tris-buffered saline (TBS), 0.5 M, (pH 7.4), for 30 minutes at room temperature; 3% hydrogen peroxide (to block endogenous peroxidase) for 5 minutes at room temperature; 3% normal goat serum in TBS for 30 minutes at room temperature; rabbit anti-substance P, 1:500 in TBS containing 1% normal goat serum, for 24 hours at 4˚C; goat anti-rabbit serum, 1:20 in TBS containing 1% normal goat serum, for 30 minutes at room temperature; rabbit peroxidase-antiperoxidase complex, 1:200 in TBS containing 1% normal goat serum for 30 minutes at room temperature; 0.05% diaminobenzadine hydrochloride in TBS (pH 7.4), and 0.01% hydrogen peroxide for 10 minutes at room temperature; and distilled water for 10 minutes at room temperature. Between each incubation step, the sections were rinsed twice for 5 minutes in TBS, except after incubation in 3% normal goat serum, which was removed by tilting the slide. The sections were dehydrated in a graded ethanol and xylene series and secured under a coverslip with Permount.
For use as a control for immunohistochemical specificity, rabbit anti-substance P was replaced on adjacent sections by normal goat serum. No staining was seen in these negative controls. Cross-reactivity testing of substance P antisera by the supplier determined that there was no reaction with the following: neurokinin A, neurokinin B, eledosin, cholecystokinin-8, serotonin, somatostatin, leucine enkephalin, methionine enkephalin, neurotensin, and vasoactive intestinal peptide.
Preparations were viewed through a microscope and photographed at magnifications ranging from ϫ 10 to ϫ 1000. The gray matter laminae were identified according to the classifications of Rexed 56 and Schoenen.
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Sources of Supplies
Rabbit anti-substance P was obtained from Incstar, Stillwater, MN. Goat anti-rabbit serum, rabbit peroxidase-antiperoxidase complex, and diaminobenzadine hydrochloride were provided by Sigma Chemical Co., St. Louis, MO.
Results
Normal Spinal Cords
Serial sections through seven levels of 10 normal spinal cords revealed substance P-like immunoreactivity in long varicosities and punctate processes in close apposition to neurons in the dorsal horn ( Fig. 1) , the intermediate gray matter, and the ventral horn. At all levels of the spinal cord, the largest amount of peroxidase-positive staining was found in the first, second, and third laminae of the dorsal horn. Less intense immunoreactivity, reflecting a smaller number of stained profiles, was present in the fifth lamina of the dorsal horn, the intermediolateral nucleus, the intermediomedial nucleus, and the ventral horn.
Spinal Cords From Patients With Syringomyelia
Syrinx cavities were associated with consistent abnormalities in substance P staining. In nine of 10 spinal cords, there was a marked reduction or absence of substance P immunoreactivity in the dorsal horn, the intermediate gray matter, and the ventral horn involving segments of the spinal cord occupied by the syrinx (Fig. 2) . Symmetrically enlarged central cavities were found to produce bilateral decreases in staining whereas eccentric or lateralized cavities produced an ipsilateral decrease, often with no reduction contralaterally (Fig. 3 ). An absence of substance P staining was observed with gross expansions (see Fig. 2 left) and with cavitations that extended into specific quad-J. Neurosurg. / Volume 84 / June, 1996 Substance P distribution in syringomyelia FIG. 1. Photomicrographs of axial sections of the normal human spinal cord at T-8 demonstrating substance P-like immunoreactivity. Left and Center: Peroxidase-antiperoxidase reaction product (arrows) is present in the first, second, and third laminae of the dorsal horn and, to a lesser extent, in the fifth lamina. Original magnifications ϫ 20 (left) and ϫ 100 (center). Right: High-power magnification of the first through third laminae reveals substance P staining in long varicosities and terminal-like processes. Original magnification ϫ 400. Roman numerals are used to designate the laminae.
rants of the spinal cord (see Fig. 2 right). Rostral to syrinx cavities, the distribution of substance P-like immunoreactivity was essentially the same as that in normal sections at comparable levels.
Immediately caudal to syrinx cavities, there was a striking increase in substance P staining in the first, second, third, and fifth laminae of the dorsal horn (Fig. 4) . The intensity of staining was attributable to a markedly increased number of long varicosities and terminal-like processes (Fig. 5 ), which were found on serial sections extending one to five levels below the lesion. Central cavities were associated with a bilateral increase in dorsal horn staining (see Fig. 4 ); lateralized cavities that were confined to one hemicord tended to produce an increase in dorsal horn staining on the ipsilateral side as compared to the contralateral side (Fig. 6 ). The intensity of the staining in the intermediate gray matter and the ventral horn of the spinal cord immediately caudal to the syrinx cavities was similar to that observed on control sections at comparable levels.
No abnormalities were observed in the distribution of substance P-like immunoreactivity in the spinal cord of one patient with a small central syrinx of unknown etiology (Case 10). The lesion was lined entirely by ependyma, occupied no more than 25% to 30% of the transverse diameter of the spinal cord, and was found incidentally at the time of autopsy. A previous report of this case (cited therein as Case 1) 41 indicated that the lesion had been asymptomatic during life.
Discussion
Substance P is an oligopeptide that has attracted considerable attention because of its apparent role in the perception and modulation of pain. The peptide is distributed widely throughout the nervous system including the brain, brainstem, spinal cord, dorsal root ganglia, and autonomic ganglia. 21, 33, 61 There is strong biochemical and physiological evidence that substance P is released from primary afferent terminals that synapse on dorsal horn neurons and produce excitatory postsynaptic potentials (EPSPs) and membrane depolarization. 19, 26, 45, 48, 49, 55, 65 It is generally agreed that substance P is an excitatory or pain-upregulating transmitter of nociceptive information. 1, 21, 69 Substance P may also be involved in antidromic vasodilation 31 and appears to play a role in synaptic transmission in autonomic ganglia. Experimental studies have suggested that substance P is released from axon collaterals of primary visceral afferent neurons in prevertebral ganglia where it generates noncholinergic slow EPSPs in principal cells. 27, 28, 36, 48 The distribution of substance P in the human spinal cord has been described previously by LaMotte and de Lanerolle 30 and by others. 5, 18, 23, 51 In normal individuals, the peptide is localized in the first, second, third, and fifth laminae of the dorsal horn, the intermediolateral nucleus, the intermediomedial nucleus, and the ventral horn. The concentration of the peptide, as reflected by the number of peroxidase-positive stained profiles, is significantly greater in the first, second, and third laminae than in other areas and this disparity is present at all levels of the spinal cord. The distribution of substance P in the spinal cords of the 10 normal subjects in the current study was consistent with these data. We observed that excellent results could be achieved using peroxidase-antiperoxidase immunohistochemical preparations of formalin-fixed, paraffinembedded materials as old as 31 years (2- 5.7 years), which supports the view that substance P is an extremely stable peptide post mortem. 6, 13, 25 Information concerning the effects of pathological processes on the distribution of substance P in the human spinal cord is limited. In patients undergoing limb amputation, a depletion of substance P and an increase of metenkephalin was observed in the medial two-thirds of the dorsal horn on the side of amputation. 23 Several studies have reported a loss of substance P-like immunoreactive fibers in the ventral horn of patients with motor neuron disease, 18, 50, 60 and Pearson, et al., 51 have described a depletion of substance P in the substantia gelatinosa of the spinal cord and the medulla oblongata of patients with familial dysautonomia (Riley-Day syndrome).
The current study is the first to examine substance P distribution in syringomyelia. As an extension of previous work on the anatomy, pathology, and clinicopathological correlates of spinal cord cavitation, 39, 40, 42 we used spinal cord specimens that had been part of an earlier study on the histopathology of syringomyelia. 39 Two consistent abnormalities in substance P staining were noted: a generalized reduction in stained profiles in segments of the spinal cord occupied by the syrinx and an increase in substance P-like immunoreactive fibers in the dorsal horn caudal to the syrinx.
The reduction in the concentration of substance P in segments of the spinal cord occupied by syrinx cavities has several possible explanations. In experimental studies, substance P levels fall in the dorsal horn after sectioning of the dorsal root 2, 7 or peripheral nerve. 3, 24 This suggests that spinal cord cavitation may interfere with the axonal transport of substance P from peripheral sites by one or more mechanisms, such as compression of the parenchyma or degeneration of primary afferent terminals. Paracentral or extracanalicular cavitations that extended to the dorsal horn were sometimes associated with a total loss of immunoreactivity (see Fig. 2 ), which is consistent with pathological evidence that such lesions produce widespread neuronophagia and wallerian degeneration. 39 Another explanation for the reduced concentration of substance P at the level of cavitation is the possibility that the lesion destroys an intrinsic source of substance P or interferes with axoplasmic flow of the peptide in the spinal cord.
The observation that substance P-like immunoreactivity was increased in the dorsal horns caudal to the level of cavitation is of particular interest. Naftchi, et al., 43 have reported that following transection of the spinal cord, substance P accumulates in the dorsal horns below the lesion and is depleted in the substantia gelatinosa above the lesion. These and other data have suggested that substance P moves in a rostral direction along an ascending pathway, 35, 43, 68 in contrast to the downward movement of monoamine transmitters from the brainstem. 9, 44 The current study is the first to demonstrate an accumulation of substance P in the human spinal cord. The increase was observed below the level of cavitation and extended caudally for only one to five spinal segments. Assuming that substance P is concentrated predominantly in afferent terminals, this finding is consistent with the proposition that substance P moves in a rostral direction by axoplasmic flow and that this movement can be impaired by structural lesions of the spinal cord.
There was insufficient information in the autopsy records of 10 patients with syringomyelia to correlate clinical findings with abnormalities in substance P staining. No abnormalities were present in one patient with an asymptomatic syrinx found incidentally at the time of autopsy (Case 10). Because substance P is a putative pain-related peptide, its role in central pain syndromes is of clinical importance. Pain is a complaint in 50% to 90% of patients with syringomyelia, 12, 15, 17, 53 and segmental dysesthesias, characterized by burning pain, hyperesthesia, and trophic changes, are present in up to 40% of patients with posttraumatic syringomyelia. 32, 34, 66, 67 It is important to emphasize that the alterations in substance P distribution reported in the current study may represent nonspecific findings. Decreased staining of the peptide at the level of the syrinx is most likely due to the local destruction of spinal cord tissue, whereas the significance of increased staining below the level of cavitation cannot be established without detailed information about the presence or absence of pain syndromes in these patients. Future studies are warranted to examine the distribution of substance P and other biologically active peptides in patients with structural lesions of the spinal cord who have well-documented clinical findings. shows an apparent increase in substance P staining in the first, second, third, and fifth laminae as compared to the contralateral dorsal horn (right). Peroxidase-antiperoxidase, original magnification ϫ 100. Roman numerals are used to designate the laminae.
